Brachytherapy

Papers
(The TQCC of Brachytherapy is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)
ArticleCitations
Effects of a novel form of intraoperative radiation therapy on quality of life among patients with early-stage breast cancer29
Patient-controlled epidural analgesia, patient-controlled intravenous analgesia, and conventional intravenous opioids for gynecologic interstitial brachytherapy: A single-center retrospective study28
Masthead28
Editorial Board22
Patient assessment of lower urinary tract symptoms using the international prostate symptom score following low-dose-rate prostate brachytherapy20
Biochemical outcome of prostate cancer patients treated with hypofractionated external radiation and a single high-dose-rate brachytherapy boost20
HDR brachytherapy combined with external beam radiotherapy for unfavorable localized prostate cancer: A single center experience from inception to standard of care16
Editorial Board14
Dosimetry and Monte Carlo modelling of the Papillon+ contact X-ray brachytherapy device13
High-dose-rate brachytherapy with surface applicator in penile cancer13
Evaluating the relationship between vaginal apex “dog ears” and patterns of recurrence in endometrial cancer following adjuvant image guided vaginal cuff brachytherapy11
Intraprostatic calcification and biochemical recurrence in men treated with cesium-131 prostate brachytherapy11
Masthead10
Masthead10
Pilot study to assess sexual function, quality of life (QOL) and change in vaginal dimensions following vaginal brachytherapy (VBT)10
PSOR4  Presentation Time: 11:45 AM9
PSOR8  Presentation Time: 12:05 PM9
PHSPP02  Presentation Time: 2:40 PM9
PSOR5  Presentation Time: 11:50 AM9
PO149
PO50  Presentation Time: 10:00 AM8
PO29  Presentation Time: 7:40 AM8
Editorial Board8
ABS21 Author Index8
Saturday, June 18, 20227:40 AM - 5:00 PMPO22  Presentation Time: 7:40 AM8
PO51  Presentation Time: 10:00 AM8
PO35  Presentation Time: 10:30 AM8
Saturday, June 18, 20223:45 PM - 4:45PM MSS01  Presentation Time: 3:45 PM7
MSS10  Presentation Time: 4:30 PM7
GSOR5  Presentation Time: 9:20 AM7
MSS07  Presentation Time: 4:15 PM7
GSOR7  Presentation Time: 9:30 AM7
Saturday, June 18, 20222:00 PM - 3:00 PM PL01  Presentation Time: 2:00 PM7
GSOR2  Presentation Time: 9:05 AM7
PP08  Presentation Time: 10:40 AM7
PO756
PO066
PO576
PO096
PO446
PO636
PO786
PO246
PO626
PP11  Presentation Time: 11:10 AM6
PO166
PO476
PO706
PO026
PO316
GSOR21  Presentation Time: 12:10 PM6
PO226
PO556
PP18 Presentation Time: 4:15 PM5
MSOR01 Presentation Time: 10:00 AM5
MSOR08 Presentation Time: 10:35 AM5
PO575
MSOR11 Presentation Time: 10:50 AM5
PLEN03 Presentation Time: 1:45 PM5
PHSOR02 Presentation Time: 10:05 AM5
MSOR03 Presentation Time: 10:10 AM5
PO485
PO555
PP15 Presentation Time: 3:48 PM5
PP12 Presentation Time: 11:50 AM5
PHSOR04 Presentation Time: 10:15 AM5
PO545
PP05 Presentation Time: 10:40 AM5
PSOR12  Presentation Time: 5:25 PM4
PO874
PP13 Presentation Time: 3:30 PM4
MSOR06 Presentation Time: 10:15 AM4
GSOR02 Presentation Time: 2:35 PM4
PP07 Presentation Time: 11:00 AM4
GSOR03  Presentation Time: 12:10 PM4
PO1084
MSOR11  Presentation Time: 5:35 PM4
GSOR10  Presentation Time: 12:45 PM4
PP02  Presentation Time: 4:39 PM4
PO944
PP15 Presentation Time: 3:48 PM4
PLEN02 Presentation Time: 1:30 PM4
PP11 Presentation Time: 11:30 AM4
PSOR03  Presentation Time: 12:10 PM4
PRSOR11 Presentation Time: 12:50 PM4
PO1044
MSOR5  Presentation Time: 5:05 PM4
PO934
PHSOR04 Presentation Time: 10:15 AM4
PRSOR02 Presentation Time: 12:05 PM4
Plenary Session Thursday, June 24, 2021 1:15 PM - 2:15 PM PLEN01 Presentation Time: 1:15 PM4
PP08 Presentation Time: 11:10 AM4
PP21 Presentation Time: 3:40 PM4
PO054
MSOR07  Presentation Time: 9:00 AM4
PO1054
PP37 Presentation Time: 11:50 AM3
PO1263
PO163
PO353
Table of Contents3
Feasibility of quantitative diffusion-weighted imaging during intra-procedural MRI-guided brachytherapy of locally advanced cervical and vaginal cancers3
Embracing a future of progress in gynecologic brachytherapy3
GSOR03 Presentation Time: 2:40 PM3
Breast brachytherapy: Building a bright future on the foundation of a rich history of advancement in technology, technique, and patient-centered care3
Table of Contents3
PO053
Role of brachytherapy in stage III endometrial cancer treated with adjuvant chemotherapy: Identifying factors predictive of a survival benefit3
GSOR09 Presentation Time: 3:10 PM3
PRSOR01 Presentation Time: 12:00 PM3
PRSOR02 Presentation Time: 12:05 PM3
PO1173
PRSOR06 Presentation Time: 12:25 PM3
PO323
A new way to visualize prostate brachytherapy needles using ultrasound color Doppler and needle surface modifications3
Editorial Board3
Comparison of AUA and phoenix definitions of biochemical failure following permanent brachytherapy for prostate cancer3
PO103
Editorial Board3
Table of Contents3
PO043
A multipurpose brachytherapy catheter to enable intratumoral injection3
GSOR11 Presentation Time: 3:20 PM3
PRSOR04 Presentation Time: 12:15 PM3
Editorial Board3
PO1153
PO203
PO223
Underutilization of brachytherapy for cervical cancer in the United States3
Effects of pain management using nonsteroidal anti-inflammatory drug suppositories during brachytherapy for cervical cancer: A single-center prospective observational study3
Late genitourinary and gastrointestinal toxicity and radiation-induced second primary cancers in patients treated with low-dose-rate brachytherapy3
PO123
Table of Contents3
Artificial intelligence applications in brachytherapy: A literature review3
PO1073
GSOR01 Presentation Time: 2:30 PM3
PSOR03 Presentation Time: 11:40 AM2
PO04062
PO02562
MSOR07 Presentation Time: 8:30 AM2
MPP04 Presentation Time: 4:27 PM2
PPP03 Presentation Time: 10:48 AM2
PHSOR09 Presentation Time: 9:40 AM2
PHSOR06 Presentation Time: 9:25 AM2
PO02502
MPP02 Presentation Time: 4:09 PM2
PO02472
PPP02 Presentation Time: 10:39 AM2
Feasibility of internal-source tracking with C-arm CT/SPECT imaging with limited-angle projection data for online in vivo dose verification in brachytherapy: A Monte Carlo simulation study2
First clinical implementation of GammaTile permanent brain implants after FDA clearance2
Thursday, July 11, 20245:00 PM - 6:00 PM GSOR01 Presentation Time: 5:00 PM2
PO04252
PO01142
PP03 Presentation Time: 4:18 PM2
GSOR02 Presentation Time: 11:35 AM2
PO02272
BP08 Presentation Time: 5:03 PM2
Thursday, July 11, 202410:30 AM - 11:30 AMPPP01 Presentation Time: 10:30 AM2
PO04172
Thursday, July 11, 20244:00 PM - 5:00 PM MPP01 Presentation Time: 4:00 PM2
PO02172
PO02242
Masthead2
PPP04 Presentation Time: 10:57 AM2
Morbidity following image-guided brachytherapy for cervical cancer: Patient and treatment related factors2
Salvage image-guided freehand interstitial brachytherapy for pelvic sidewall recurrence after hysterectomy for uterine malignancies2
Editorial Board2
GYN Posters PO02012
PO02492
PO04152
BP02 Presentation Time: 4:09 PM2
PO02532
PPP03 Presentation Time: 10:48 AM2
PO04042
GSOR04 Presentation Time: 5:15 PM2
GPP06 Presentation Time: 9:45 AM2
PO03242
PO03062
Author Index2
Thursday, July 11, 20249:00 AM - 10:00 AMGPP01 Presentation Time: 9:00 AM2
PO02442
Iodine-125 brachytherapy for a desmoid tumor in the abdomen-thorax: A retrospective study2
Editorial Board2
PO01202
PP05 Presentation Time: 4:36 PM2
Table of Contents1
Acute and late complications and toxicities of skin brachytherapy1
Masthead1
A multiobserver study investigating the effectiveness of prostatic multiparametric magnetic resonance imaging to dose escalate corresponding histologic lesions using high-dose-rate brachytherapy1
Is hemi-gland focal LDR brachytherapy as effective as whole-gland treatment for unilateral prostate cancer?1
Editorial Board1
Definitive radiation for advanced cervix cancer is not associated with vaginal shortening—a prospective vaginal length and dose correlation1
Palliative treatment with high-dose-rate endobronchial interventional radiotherapy (Brachytherapy) for lung cancer patients1
PO351
Table of Contents1
Toward a deep learning-based magnetic resonance imaging only workflow for postimplant dosimetry in I-125 seed brachytherapy for prostate cancer1
The case for risk-stratified IORT for early breast cancer1
Redefining the role of pulsed-dose-rate brachytherapy in cervical cancer treatment using a preplanned approach1
Local seed displacement from Day 0 to Day 30 in I-125 permanent prostate brachytherapy: A detailed, computed tomography-based analysis1
Re-treatment of locally recurrent uveal melanoma with repeat eye plaque I-125 brachytherapy: A single institution experience1
Management of ductal carcinoma in situ with accelerated partial breast irradiation brachytherapy: Implications for guideline expansion1
Determination of Ir-192 micrselectron-V2 HDR/PDR dwell position reproducibility using a slit camera1
Management of locally advanced mesonephric carcinoma of the cervix in the setting of Mullerian Duct anomaly spectrum and unilateral renal agenesis: A case report and review of the literature1
Radical trachelectomy and adjuvant vaginal brachytherapy to preserve fertility in pediatric cervical adenocarcinoma1
Table of Contents1
Therapeutic and prophylactic effects of radiation therapy in the management of recurrent granulation tissue induced tracheal stenosis: a review on the role of Endobronchial brachytherapy and external 1
HDR brachytherapy in keratinocyte skin carcinomas - Single center experience with analysis of clinical, dosimetric, and radiobiological factors in acute skin toxicity1
Comparison of TG43 and Hounsfield Unit–based TG186 brachytherapy dose metrics in Oncentra Brachy for 100 patients receiving interstitial partial breast irradiation1
Editorial Board1
Cs-131 prostate brachytherapy boost and effect of hydrogel rectal spacer on long-term patient-reported rectal bleeding and bowel quality of life1
Outcomes for posterior uveal melanoma: Validation of American Brachytherapy Society Guidelines1
Coronary intravascular brachytherapy for in-stent restenosis: A review of the contemporary literature1
The impact of a positive COVID-19 test on timeliness of radiation in patients receiving brachytherapy1
A feasibility study of utilizing a cadaveric training model for novel robotic bladder cancer brachytherapy techniques1
Development and clinical implementation of simple needle attachment post placement interstitial template (SNAPP-IT) enabling a shorter, more direct needle path while preserving tumor visualization1
The birth, decline, and contemporary re-emergence of endovascular brachytherapy for prevention of in-stent restenosis1
Redefining bladder neck dose in low-dose-rate prostate brachytherapy–Can we improve urinary toxicity without impacting disease control?1
Comparison of dose delivered to vagina using two different intracavitary brachytherapy applicators for carcinoma cervix1
Low-Dose-Rate versus High-Dose-Rate intracavitary brachytherapy in cervical cancer - Final Results of a Phase III randomized trial1
Complications of intracavitary brachytherapy for gynecologic cancers and their management: A comprehensive review1
Acute toxicity and health-related quality of life outcomes of localized prostate cancer patients treated with magnetic resonance imaging-guided high-dose-rate brachytherapy: A prospective phase II tri1
Evaluation and improvement of the safety of 3D-printed template assisted intracavitary/interstitial brachytherapy for cervical cancer using repeat FMEA1
Radiation dose rate variations in different measurement scenarios after prostate 125I brachytherapy1
Patient-reported outcomes after Low-dose-rate versus High-dose-rate brachytherapy boost in combination with external beam radiation for intermediate and high risk prostate cancer1
Dosimetric study of Varian Universal Multi-Channel Cylinder System for High-Dose-Rate 192Ir Brachytherapy1
Table of Contents1
Response to letter to the editor with regards to “Impact of detector selection on commissioning of Leipzig surface applicators with improving immobilization in high-dose-rate brachytherapy” by Li et a1
Optimizing surface mould brachytherapy for treatment of nasal basal cell carcinoma using customized applicators1
Re: Letter to the editor with regards to “Impact of detector selection on commissioning of Leipzig surface applicators with improving immobilization in high-dose-rate brachytherapy” by Li et al.1
Clinical characteristics and postoperative complications as predictors of radiation toxicity after treatment with I125 Eye Plaque Brachytherapy for Uveal Melanomas1
Novel portable apparatus for outpatient high-dose-rate (HDR) brachytherapy in penile cancer1
Masthead1
Geographic access to brachytherapy services in the United States1
Table of Contents1
Safety of high-dose rate (HDR) brachytherapy for patients with prostate cancer and history of prior chemoradiation for rectal cancer: A case series1
A practical method of estimating medium-heterogeneity corrected dose without a Monte Carlo calculation in ocular brachytherapy using 125I COMS plaques1
HDR brachytherapy as monotherapy for prostate cancer: A systematic review with meta-analysis1
Learning curve and proficiency assessment for gynecological brachytherapy amongst radiation oncology trainees in India: Results from a prospective study1
A simple calibration routine for small inorganic scintillation detectors for in vivo dosimetry during brachytherapy1
Editorial Board1
A versatile physical phantom design and construction for I-125 dose measurements and dose-to-medium determination1
Feasibility of electronic brachytherapy in cervix cancer–A dosimetric comparison of different brachytherapy techniques1
CT-guided iodine-125 brachytherapy is an effective palliative treatment for the right lower paratracheal lymph nodes metastasis previously treatment failure1
Age, racial, and ethnic disparities in reported clinical studies involving brachytherapy1
High-dose-rate brachytherapy for airway malignancy a single institution experience1
Heterogeneous physical phantom for I-125 dose measurements and dose-to-medium determination1
Long-term oncologic outcomes of low dose-rate brachytherapy compared to hypofractionated external beam radiotherapy for intermediate -risk prostate cancer1
Long-term disease-free survival following salvage brachytherapy for recurrent pediatric rhabdomyosarcoma: Two case reports and review of relevant literature1
Computed tomography guided interstitial percutaneous high-dose-rate brachytherapy in the management of lung malignancies. A review of the literature1
Reducing dose to rectum by placement of a rectum-emptying tube in cervical cancer patients treated with brachytherapy1
0.062422037124634